Spreadex Market Update
FTSE 100 heads into the afternoon trading in the red
The FTSE 100 headed into afternoon trading still in the red, dragged down by a new twist in the AstraZeneca/Pfizer takeover bid. Shares in AZN fell over 13% as news surfaced that they rejected Pfizer’s £69bn final takeover offer as it “undervalues the company and its attractive prospects” and “presents significant risks for shareholders”. The AstraZeneca board has recently said they are a ‘bit surprised’ to see the new updated bid.
With a very thin economic calendar for today, US futures are pointing towards a weaker open as there is little data which can be used as a catalyst for any significant direction whilst more M&A activity hit investors. AT&T have agreed to buy DirecTV for roughly $48.5bn which was announced on Sunday, however shares have dropped 2.4% during premarket today.
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.
